Literature DB >> 17350948

Advances in the treatment of localized prostate cancer: the role of anatomic and functional imaging in men managed with radiotherapy.

Joycelyn L Speight1, Mack Roach.   

Abstract

Radiation therapy is an active modality in the management of local and regional prostate cancer, but can be curative only if all existing disease is encompassed within the treatment portal. In addition to the ability to deliver sufficient radiation dose, accurate targeting is critical to achieve better treatment outcomes. Failure to accommodate daily variations in setup and organ motion potentially limits the efficacy of sophisticated conformal techniques (three-dimensional conformal radiotherapy and intensity-modulated radiotherapy). Increased use of various online and real-time imaging techniques is an important step toward enhancing treatment accuracy. The incorporation of functional imaging techniques into treatment planning is another important step. The addition of biologic and metabolic information regarding the location and extent of disease combined with real-time online imaging will allow us to better determine where, how, and with what to treat appropriate targets and improve cure rates.

Entities:  

Mesh:

Year:  2007        PMID: 17350948     DOI: 10.1200/JCO.2006.10.3218

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  8 in total

Review 1.  "No Turning Bax" in the combined battle against prostate cancer:.

Authors:  Ramji R Rajendran; Gary D Kao
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

2.  Prostate cancer: worse sexual function after cryoablation--a case for EBRT?

Authors:  Mack Roach
Journal:  Nat Rev Urol       Date:  2010-03       Impact factor: 14.432

3.  Quantitative evaluation of internal marks made using MRgFUS as seen on MRI, CT, US, and digital color images - a pilot study.

Authors:  Elizabeth Hipp; Xiaobing Fan; Ari Partanen; James Vosicky; Charles A Pelizzari; Christopher M Straus; Sham Sokka; Gregory S Karczmar
Journal:  Phys Med       Date:  2014-05-17       Impact factor: 2.685

4.  Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy.

Authors:  C Onal; S Sonmez; G Erbay; O C Guler; G Arslan
Journal:  Br J Radiol       Date:  2013-12-06       Impact factor: 3.039

Review 5.  Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer.

Authors:  Petras Juzenas; Wei Chen; Ya-Ping Sun; Manuel Alvaro Neto Coelho; Roman Generalov; Natalia Generalova; Ingeborg Lie Christensen
Journal:  Adv Drug Deliv Rev       Date:  2008-09-20       Impact factor: 15.470

6.  Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer.

Authors:  Suzanne E Lapi; Hilla Wahnishe; David Pham; Lisa Y Wu; Jessie R Nedrow-Byers; Tiancheng Liu; Kaveh Vejdani; Henry F VanBrocklin; Clifford E Berkman; Ella F Jones
Journal:  J Nucl Med       Date:  2009-11-12       Impact factor: 10.057

7.  Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI.

Authors:  Katherine Amarell; Anna Jaysing; Christopher Mendez; Jonathan A Haas; Seth R Blacksburg; Aaron E Katz; Astrid Sanchez; Angela Tong; Todd Carpenter; Matthew Witten; Sean P Collins; Jonathan W Lischalk
Journal:  Radiat Oncol       Date:  2022-04-02       Impact factor: 3.481

8.  Computer aided detection in prostate cancer diagnostics: A promising alternative to biopsy? A retrospective study from 104 lesions with histological ground truth.

Authors:  Anika Thon; Ulf Teichgräber; Cornelia Tennstedt-Schenk; Stathis Hadjidemetriou; Sven Winzler; Ansgar Malich; Ismini Papageorgiou
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.